|
|
|
|
LEADER |
00000nam a22000005i 4500 |
001 |
978-3-642-15742-4 |
003 |
DE-He213 |
005 |
20220120011748.0 |
007 |
cr nn 008mamaa |
008 |
110414s2011 gw | s |||| 0|eng d |
020 |
|
|
|a 9783642157424
|9 978-3-642-15742-4
|
024 |
7 |
|
|a 10.1007/978-3-642-15742-4
|2 doi
|
050 |
|
4 |
|a RC86-88.9
|
072 |
|
7 |
|a MMKL
|2 bicssc
|
072 |
|
7 |
|a MED015000
|2 bisacsh
|
072 |
|
7 |
|a MKPL
|2 thema
|
082 |
0 |
4 |
|a 616.028
|2 23
|
245 |
1 |
0 |
|a Pulmonary Involvement in Patients with Hematological Malignancies
|h [electronic resource] /
|c edited by Elie Azoulay.
|
250 |
|
|
|a 1st ed. 2011.
|
264 |
|
1 |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg :
|b Imprint: Springer,
|c 2011.
|
300 |
|
|
|a XIX, 827 p. 161 illus., 63 illus. in color.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
505 |
0 |
|
|a Preamble and Introduction.-Epidemiology -- Diagnostic Strategy in Hematologic Malignancies Patients -- Lung Infections in Patients with Hematologic Malignancies.-Noninfectious Pulmonary Involvement in Patients with Hematologic Malignancies -- Treatment and Difficult Decisions in Patients with Hematologic Malignancies.-Pearls that You Should be Aware of.-Post Face.
|
520 |
|
|
|a The number of patients treated for hematological malignancies is increasing steadily. To obtain the highest possible cure rates, aggressive treatments have been introduced, including high-dose chemotherapy, stem cell transplantation, and targeted therapies. As a result, overall and disease-free survival rates have improved substantially; however, this has been achieved at the price of life-threatening toxic and infectious complications that chiefly target the lung. This book provides clinicians caring for patients with hematological malignancies with detailed, up-to-date information on all relevant aspects of pulmonary involvement. Individual sections are devoted to epidemiology, diagnostic strategy, lung infections, non-infectious pulmonary involvement, and treatment, including decision making in patients with acute respiratory failure. Each of these sections contains a number of chapters, all written by leading international experts. In addition, the reader's attention is drawn to important "pearls" relating to each condition.
|
650 |
|
0 |
|a Critical care medicine.
|
650 |
|
0 |
|a Hematology.
|
650 |
|
0 |
|a Oncology.
|
650 |
|
0 |
|a Diseases.
|
650 |
|
0 |
|a Respiratory organs-Diseases.
|
650 |
1 |
4 |
|a Intensive Care Medicine.
|
650 |
2 |
4 |
|a Hematology.
|
650 |
2 |
4 |
|a Oncology.
|
650 |
2 |
4 |
|a Diseases.
|
650 |
2 |
4 |
|a Pneumology.
|
700 |
1 |
|
|a Azoulay, Elie.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer Nature eBook
|
776 |
0 |
8 |
|i Printed edition:
|z 9783642157417
|
776 |
0 |
8 |
|i Printed edition:
|z 9783642157431
|
776 |
0 |
8 |
|i Printed edition:
|z 9783662518380
|
856 |
4 |
0 |
|u https://doi.uam.elogim.com/10.1007/978-3-642-15742-4
|z Texto Completo
|
912 |
|
|
|a ZDB-2-SME
|
912 |
|
|
|a ZDB-2-SXM
|
950 |
|
|
|a Medicine (SpringerNature-11650)
|
950 |
|
|
|a Medicine (R0) (SpringerNature-43714)
|